KATHRINE JIBBEN: Open Payments
NPI 1841320983 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 77 payments from 16 companies in 2025. Trend: 2023 $886 · 2024 $1,341 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $368 |
| Janssen Biotech, Inc. | 7 | $138 |
| Novartis Pharmaceuticals Corporation | 8 | $132 |
| Lilly USA, LLC | 10 | $128 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $103 |
| GENZYME CORPORATION | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| Amgen Inc. | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| UCB, Inc. | 3 | $67 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, BOTOX, COSENTYX, EBGLYSS, OTEZLA, Sotyktu.
Industry payments across SD — which companies pay providers there.
